Enhanced CAR-T cell persistence, proliferation, and fitness through NF-kB and/or PI3K-Akt-mTOR activityLower serum cytokine levels (IL-6, IL-10) and reduced instances of > grade 2 CRSIncreased speed of tumor clearance and greater long-term tumor control. The gene discussed is MTOR; the disease is neoplasm.